CIK 0001855175 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 0 | |
| Net income (USD) | -60.0 M | 22.7 M |
| Diluted EPS (USD/shares) | -2.17 | 0.08 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-01 | 144 | 144 | |
| 2026-09-14 | 8-K | 8-K items 8.01,9.01 | 2026-09-14 |
| 2026-09-08 | 4 | FORM 4 | 2026-09-08 |
| 2026-09-08 | 144 | 144 | |
| 2026-09-01 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-03 | 4 | FORM 4 | 2026-08-03 |
| 2026-08-03 | 144 | 144 | |
| 2026-08-03 | 144 | 144 | |
| 2026-07-30 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 8-K | 8-K items 2.02,9.01 | 2026-07-30 |
| 2026-07-27 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-17 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-13 | 8-K | 8-K items 7.01,9.01 | 2026-07-13 |
| 2026-07-10 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-08 | 4 | FORM 4 | 2026-07-08 |
| 2026-07-08 | 144 | 144 | |
| 2026-07-02 | 4 | FORM 4 | 2026-06-30 |
| 2026-07-01 | 4 | FORM 4 | 2026-06-30 |
| 2026-07-01 | 4 | FORM 4 | 2026-06-30 |
| 2026-07-01 | 144 | 144 | |
| 2026-06-30 | 144 | 144 | |
| 2026-06-30 | 144 | 144 | |
| 2026-06-30 | 144 | 144 | |
| 2026-06-26 | 4 | FORM 4 | 2026-06-26 |
Forms on file (last 1,000): 4 63, 8-K 26, 144 20, 3 15, SCHEDULE 13G/A 11, 10-Q 8, SCHEDULE 13G 7, CORRESP 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CTNM (0.002 USD), /gw/filings/filings?ticker=CTNM&form=8-K, /gw/filings/facts?ticker=CTNM&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange